Contemporary Compounding

July 13, 2018

Phenylephrine HCl 0.5%, Naphazoline HCl 0.05%, and Pyrilamine Maleate 0.2% Nasal Spray

This nasal decongestant has antihistaminic properties.

June 15, 2018

Metronidazole 2%, Misoprostol 0.003%, Nifedipine 2%, and Phenytoin 5% Gel

May 18, 2018

Levofloxacin 50 mg/mL Oral Suspension

April 13, 2018

Nitrofurazone 0.02% Nasal Solution/Spray

March 16, 2018

Amitriptyline HCl 2%, Baclofen 5%, Ketamine HCl 5%, and Ketoprofen 10% in Pluronic Lecithin Organogel

February 16, 2018

Sildenafil Citrate 2.5 mg/mL Oral Liquid

January 19, 2018

Ethotoin 50 mg/mL Oral Suspension

December 15, 2017

Ranitidine Hydrochloride 25 mg/mL Syrup (Alcohol-Free)

November 17, 2017

Memantine Hydrochloride 2 mg/mL Oral Solution, Thickened

October 13, 2017

Nebivolol HCl 2.5 mg/5 mL and Valsartan 40 mg/5 mL Oral Suspension

September 15, 2017

Progesterone 50 mg/g in VersaBase Cream

August 18, 2017

Chlorhexidine Digluconate 0.05% in Normal Saline Bladder Irrigation

July 19, 2017

Ethambutol Hydrochloride Compounded Oral Suspension USP (100 mg/mL)

July 2018

July 2018

In This Issue Digital Magazine Archives Subscription

Continuing Education

$6.97 Per CE Exam or $59 for 12 Lessons

Infectious Disease, Respiratory/Pulmonary • July 2020 • 2.00 Credits

Treatment and Management of Upper Respiratory Tract Infections
Dermatology • June 2020 • 2.00 Credits

Drug-Induced Severe Cutaneous Adverse Reactions: Potential Signals of Serious Risks/New Safety Information From FAERS
Mental Health • May 2020 • 2.00 Credits

New Therapeutic Options for the Management of ADHD

View More CE

Copyright © 2000 - 2018 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.